newsfilter
← Latest News
PR Newswire·

Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions

Eli Lilly and Company (NYSE: LLY) and AtaiBeckley Inc. (Nasdaq: ATAI), a clinical-stage biopharmaceutical company developing innovative therapeutics...